Join this webinar to explore how leading organizations are expanding their understanding and approaches to broadening data types to enable innovation.
Join Abby McDonell, Sr. Program Manager with IQVIA’s Clinical Trial Transparency Team (powered by Privacy Analytics), to gain actionable insights on optimising your medical writing processes to ...
On May 16, the European Medicines Agency (EMA) confirmed that after a long hiatus (punctuated only by COVID-related publications), Policy 0070 will officially resume in September 2023. Join Niamh ...
As a clinical trial sponsor, you’re under tight timelines to balance participant privacy and data utility in clinical document submissions while justifying and protecting commercially sensitive ...
As a clinical trial sponsor, you’re under pressure to be transparent, but how do you ensure your clinical study documents don’t reveal confidential trade secrets when published by regulators?
As a clinical trial sponsor, you were already facing tight timelines and resource constraints in handling regulatory requirements for document anonymization and redaction.
In this panel replay, you’ll get tangible strategies and tactics to identify, substantiate and communicate a compelling, urgent reason to provide internal access to sensitive data or to share ...
CDOs are increasingly becoming responsible for enterprise-wide governance and the use of information as an asset, as well as organizational data sharing & analytics strategy.
When the EU’s General Data Protection Regulation (GDPR) came into effect, Fresenius Medical Care and its affiliates were stuck sitting on insight-rich data, wondering how they could make the best use ...
Data and transparency leaders in the pharma industry are increasingly embracing the digital shift toward reusing clinical trial data for new benefits, including future trial design. Watch our webinar ...
Data privacy, handled responsibly, is your unshakable bedrock for earning trust. That earned trust will allow you to innovate in ways that can benefit everyone.
Your structured clinical trial data is an increasingly valuable resource that benefits new analytics, research, and innovation. With the pressure being put on pharma to collaborate and share trial ...
If you want to safely leverage the increasing value of your sensitive data by implementing data anonymization at scale, you’re likely facing one (or all) of these critical challenges:
What are anonymization and de-identification? Do they mean the same thing? Is there even consensus about their meaning? Luk Arbuckle draws on his deep experience in anonymization to address these ...
Strategy development can hold you back. You want to leverage your organization’s data assets, including those containing sensitive information, but you can’t get consensus on how to…
As the healthcare industry evolves into an ecosystem of data-rich, digitally enabled stakeholders, drug manufacturers are losing their informational advantage in the value chain.
While structured data is now commonly deidentified and used for a multitude of purposes, it’s only part of the story.
How can companies leverage the increasing business value of the sensitive data they manage (without running afoul of statutory regulations, or stakeholder trust)?
This is a co-presentation by global authorities in data and privacy, ending with a thorough, facilitated Q&A session. In the presentation, our experts share specific data privacy strategies and ...
Before CDOs can unlock data value, they must first understand data potential. Although many CDOs today are deep into analytics, it can be challenging to determine which data assets hold the most ...
Four data analytics and privacy leaders share the story of their respective journeys to either safely turn personal data into business value or earn trust by protecting the privacy of the people ...
California’s Consumer Privacy Act inspired Comcast to evolve the way in which the company protects the privacy of customers who consent to share personal information with them. Doina Iepuras, Senior ...
Data velocity and privacy concerns are colliding. Data lakes are turning into data swamps. View our webcast with world-renowned data gurus Jules Polonetsky and Luk Arbuckle.
Filter by Data Type
Categories
